Sansure Presents Advanced Diagnostic Solutions
|
By LabMedica International staff writers Posted on 04 Feb 2025 |
|
Image: Sansure is demonstrating its latest diagnostic technologies at Medlab Middle East 2025 (Photo courtesy of Sansure)
Sansure Biotech (Hunan, China) is presenting its cutting-edge healthcare solutions and providing live demonstrations of its latest diagnostic technologies at Medlab Middle East 2025.
Sansure is demonstrating its range of portable molecular diagnostic systems including the iPonatic III, iPonatic III Pro, and Q-POC. With its cutting-edge technology, iPonatic III ushers in a new “digital and intelligent” era of molecular diagnostics, empowering healthcare professionals and providing rapid and accurate results. The iPonatic III Pro combines the core technical advantages of the previous generations of iPonatic series products, and integrates better fluid controlling, magnetic beads method for nucleic acid extraction and PCR process, to avoid the traditional PCR experimental process time-consuming, complex operation and other drawbacks. The Q-POC PCR diagnostic platform enables rapid, high-quality, and on-demand multiplex PCR testing with results in approximately 30 minutes. Its flexible design allows testing in any location.
Also featured is the SureXler 48 real-time PCR instrument which is revolutionizing PCR diagnostics with its fast thermal system, completing amplification in just 30 minutes. Designed for high throughput and precision, it offers temperature uniformity at ±0.1°C and detects gene expression changes as low as 1.5-fold. Supporting up to 8 detection channels, the utmost efficiency makes it the best helper in non-clinical sample testing, pathogen detection, and genetic screening. From qualitative analysis to high-resolution melting, SureXler 48 has them all covered. Sansure is also highlighting the compact, high-performance Natch 16S nucleic acid extraction system designed for efficient DNA and RNA extraction with a throughput of 1 to 16 samples. Utilizing magnetic bead technology and 10 mixing modes, it offers quick extraction times of 10-60 minutes, making it ideal for fast-paced diagnostics in areas like women’s health, respiratory diseases, and public health.
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
 Assay.jpg)
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Latest MEDLAB 2025 News
- Medlab Middle East Rebranded to WHX Labs Dubai
- BIOBASE Showcases Comprehensive Range of Laboratory Solutions
- Dymind Presents Advanced Automatic Hematology Analysis Line
- BioPerfectus Presents Latest Solutions for Women's Health and Infectious Disease Diagnosis
- YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency
- Vazyme Showcases Cutting-Edge Microfluidic Solutions for Precise and Efficient Laboratory Workflows
- Erba Unveils New H 7100 Advanced Hematology Analyzer
- HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments
- Tianlong Presents Advanced Instruments and Cutting-Edge Reagents
- Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes
- DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel
- Fapon Presents Comprehensive Range of One-Stop IVD Solutions
- Anbio Biotechnology Showcases Cutting-Edge Diagnostic Solutions
- Sysmex Showcases Latest Laboratory Innovations and Technologies
- Snibe Demonstrates Cutting-Edge Diagnostic Solutions
- Beckman Coulter Showcases Cutting-Edge Innovations in Diagnostics
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
